The study of quantum chaos reveals its early emergence in quantum processors, affecting information scrambling and the ...

Liquids and solutions are complex environments—think, for example, of sugar dissolving in water, where each sugar molecule ...

NEW YORK, August 14, 2025--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced the discontinuation of the clinical development program for SGR-2921, its CDC7 inhibitor, which was being ...

Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the cell division cycle 7 (CDC7) inhibitor died in a Phase I trial. The trial (NCT05961839) ...

Light Publishing Center, Changchun Institute of Optics, Fine Mechanics And Physics, CAS Four decades ago, Feynman proposed the idea that the operation of a complex quantum system can be simulated by ...

Earlier this year, Schrödinger presented initial Phase 1 data for SGR-1505 in patients with relapsed/refractory B-cell malignancies. SGR-1505 was observed to be well tolerated and clinically active ...

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced that the company and Geoffrey Porges, MBBS., have mutually agreed that Dr. Porges will depart from his role as chief financial ...

This column originally appeared in the WSJ’s Markets A.M newsletter. You can sign up here to receive it in your inbox every weekday. “Fly the random skies” doesn’t have the same reassuring ring to it ...

Physicists have created a Schrödinger's cat state at unusually hot temperatures, and it could be a major step toward the development of practical quantum computers. Schrödinger's cat states exist in ...

Schrödinger's Q4 2024 results and 2025 guidance were solid, yet the company's share price remains low due to ongoing losses. Cash burn is likely to moderate going forward, as investments in the ...

Schrödinger Inc.’s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said it has entered a multi-year collaboration agreement with Swiss pharma ...